Study Details
Design, interventions, and primary outcomes
About This Study
This study evaluates whether radiotherapy can safely be omitted in breast cancer patients with T1-2N0 tumors who achieve a pathologic complete response after neoadjuvant systemic therapy and breast-conserving surgery
Design
Interventions / Regimen
- Radiation: Omission of radiotherapy — Omission of radiotherapy
Primary Outcomes
- Local recurrence (5 years)
Phase: NA
Status: Recruiting
Start Date: 2022-10-07
Completion: 2037-05
Sex: FEMALE
Volunteers: false
Enrollment: 595 (ESTIMATED)
Collaborators: Dutch Cancer Society, Borstkanker Onderzoek Groep
- Radiation: Omission of radiotherapy — Omission of radiotherapy